SRPT logo

Sarepta Therapeutics, Inc. (SRPT) Gross profit

Annual gross profit:

$1.55B+$496.56M(+47.35%)
December 31, 2024

Summary

  • As of today (August 20, 2025), SRPT annual gross profit is $1.55 billion, with the most recent change of +$496.56 million (+47.35%) on December 31, 2024.
  • During the last 3 years, SRPT annual gross profit has risen by +$978.34 million (+172.60%).
  • SRPT annual gross profit is now at all-time high.

Performance

SRPT Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

quarterly gross profit:

$447.69M-$149.62M(-25.05%)
June 30, 2025

Summary

  • As of today (August 20, 2025), SRPT quarterly gross profit is $447.69 million, with the most recent change of -$149.62 million (-25.05%) on June 30, 2025.
  • Over the past year, SRPT quarterly gross profit has increased by +$138.03 million (+44.57%).
  • SRPT quarterly gross profit is now -25.05% below its all-time high of $597.31 million, reached on March 31, 2025.

Performance

SRPT quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

TTM gross profit:

$1.93B+$138.03M(+7.72%)
June 30, 2025

Summary

  • As of today (August 20, 2025), SRPT TTM gross profit is $1.93 billion, with the most recent change of +$138.03 million (+7.72%) on June 30, 2025.
  • Over the past year, SRPT TTM gross profit has increased by +$637.41 million (+49.45%).
  • SRPT TTM gross profit is now at all-time high.

Performance

SRPT TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherSRPTincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

SRPT Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+47.4%+44.6%+49.5%
3 y3 years+172.6%+140.9%+187.7%
5 y5 years+377.8%+280.9%+404.0%

SRPT Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+172.6%-25.1%+149.3%at high+187.7%
5 y5-yearat high+377.8%-25.1%+287.8%at high+404.0%
alltimeall timeat high>+9999.0%-25.1%+5455.8%at high+7434.5%

SRPT Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$447.69M(-25.0%)
$1.93B(+7.7%)
Mar 2025
-
$597.31M(+15.8%)
$1.79B(+15.7%)
Dec 2024
$1.55B(+47.4%)
$515.65M(+41.0%)
$1.55B(+12.7%)
Sep 2024
-
$365.68M(+18.1%)
$1.37B(+6.3%)
Jun 2024
-
$309.67M(-12.6%)
$1.29B(+7.8%)
Mar 2024
-
$354.16M(+3.8%)
$1.20B(+14.0%)
Dec 2023
$1.05B(+39.6%)
$341.23M(+20.2%)
$1.05B(+13.4%)
Sep 2023
-
$283.86M(+31.2%)
$924.44M(+12.7%)
Jun 2023
-
$216.32M(+4.4%)
$820.19M(+3.9%)
Mar 2023
-
$207.18M(-4.6%)
$789.67M(+5.1%)
Dec 2022
$751.16M(+32.5%)
$217.07M(+20.9%)
$751.16M(+8.3%)
Sep 2022
-
$179.61M(-3.3%)
$693.66M(+3.6%)
Jun 2022
-
$185.80M(+10.2%)
$669.51M(+8.0%)
Mar 2022
-
$168.67M(+5.7%)
$619.83M(+9.4%)
Dec 2021
$566.82M(+26.0%)
$159.57M(+2.6%)
$566.82M(+8.4%)
Sep 2021
-
$155.47M(+14.2%)
$522.70M(+6.8%)
Jun 2021
-
$136.13M(+17.7%)
$489.52M(+3.9%)
Mar 2021
-
$115.66M(+0.2%)
$470.94M(+4.7%)
Dec 2020
$449.81M(+39.1%)
$115.45M(-5.6%)
$449.81M(+7.4%)
Sep 2020
-
$122.29M(+4.0%)
$418.71M(+9.6%)
Jun 2020
-
$117.55M(+24.4%)
$382.20M(+11.4%)
Mar 2020
-
$94.52M(+12.1%)
$343.19M(+6.1%)
Dec 2019
$323.40M(+21.6%)
$84.35M(-1.7%)
$323.40M(+4.3%)
Sep 2019
-
$85.79M(+9.2%)
$310.12M(+5.5%)
Jun 2019
-
$78.53M(+5.1%)
$293.86M(+4.2%)
Mar 2019
-
$74.73M(+5.2%)
$281.90M(+6.0%)
Dec 2018
$265.98M(+82.0%)
$71.06M(+2.2%)
$265.98M(+7.1%)
Sep 2018
-
$69.53M(+4.4%)
$248.43M(+12.4%)
Jun 2018
-
$66.58M(+13.2%)
$220.99M(+18.1%)
Mar 2018
-
$58.81M(+9.9%)
$187.15M(+31.1%)
Dec 2017
$146.18M(<-9900.0%)
$53.52M(+27.1%)
$142.80M(+53.7%)
Sep 2017
-
$42.10M(+28.6%)
$92.91M(+86.8%)
Jun 2017
-
$32.73M(+126.5%)
$49.74M(+220.3%)
Mar 2017
-
$14.45M(+298.5%)
$15.53M(-4953.1%)
Dec 2016
-$320.00K(<-9900.0%)
$3.63M(-437.7%)
-$320.00K(-91.9%)
Sep 2016
-
-$1.07M(-27.2%)
-$3.95M(-5.7%)
Jun 2016
-
-$1.48M(+5.7%)
-$4.18M(+4.6%)
Mar 2016
-
-$1.40M(<-9900.0%)
-$4.00M(+3.0%)
Dec 2015
$0.00(0.0%)
$0.00(-100.0%)
-$3.88M(0.0%)
Sep 2015
-
-$1.31M(+1.6%)
-$3.88M(+51.0%)
Jun 2015
-
-$1.29M(+0.9%)
-$2.57M(+100.9%)
Mar 2015
-
-$1.28M(<-9900.0%)
-$1.28M(<-9900.0%)
Dec 2014
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
-
$0.00(0.0%)
$0.00(-100.0%)
Mar 2013
-
$0.00(0.0%)
-$2.64M(0.0%)
Dec 2012
$0.00(-100.0%)
$0.00(0.0%)
-$2.64M(-63.4%)
Sep 2012
-
$0.00(-100.0%)
-$7.21M(-53.7%)
Jun 2012
-
-$2.64M(<-9900.0%)
-$15.57M(-19.5%)
Mar 2012
-
$0.00(-100.0%)
-$19.34M(-3.7%)
Dec 2011
$45.69M
-$4.57M(-45.4%)
-$20.09M(+29.4%)
Sep 2011
-
-$8.36M(+30.3%)
-$15.52M(-1407.4%)
Jun 2011
-
-$6.42M(+762.4%)
$1.19M(-89.4%)
DateAnnualQuarterlyTTM
Mar 2011
-
-$744.00K(<-9900.0%)
$11.25M(-12.5%)
Dec 2010
$0.00(0.0%)
$0.00(-100.0%)
$12.85M(0.0%)
Sep 2010
-
$8.35M(+128.9%)
$12.85M(+185.3%)
Jun 2010
-
$3.65M(+324.9%)
$4.50M(+424.9%)
Mar 2010
-
$858.00K(>+9900.0%)
$858.00K(>+9900.0%)
Dec 2009
$0.00(0.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2009
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2009
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2009
-
$0.00(0.0%)
$0.00(-100.0%)
Dec 2008
$0.00(0.0%)
$0.00(0.0%)
-$1.85M(0.0%)
Sep 2008
-
$0.00(0.0%)
-$1.85M(-79.0%)
Jun 2008
-
$0.00(-100.0%)
-$8.82M(-43.6%)
Mar 2008
-
-$1.85M(<-9900.0%)
-$15.63M(-20.1%)
Dec 2007
$0.00(0.0%)
$0.00(-100.0%)
-$19.56M(-25.5%)
Sep 2007
-
-$6.97M(+2.3%)
-$26.26M(+4.1%)
Jun 2007
-
-$6.81M(+17.8%)
-$25.22M(+3.7%)
Mar 2007
-
-$5.78M(-13.8%)
-$24.31M(-3.6%)
Dec 2006
$0.00(0.0%)
-$6.70M(+13.1%)
-$25.23M(+14.6%)
Sep 2006
-
-$5.93M(+0.4%)
-$22.02M(+29.8%)
Jun 2006
-
-$5.90M(-11.9%)
-$16.96M(+13.6%)
Mar 2006
-
-$6.70M(+91.6%)
-$14.93M(+81.3%)
Dec 2005
$0.00(0.0%)
-$3.50M(+304.0%)
-$8.24M(+73.7%)
Sep 2005
-
-$865.40K(-77.7%)
-$4.74M(-41.0%)
Jun 2005
-
-$3.88M(<-9900.0%)
-$8.03M(-21.8%)
Mar 2005
-
$0.00(0.0%)
-$10.27M(0.0%)
Dec 2004
$0.00(0.0%)
$0.00(-100.0%)
-$10.27M(-3.0%)
Sep 2004
-
-$4.16M(-32.0%)
-$10.59M(+10.9%)
Jun 2004
-
-$6.12M(<-9900.0%)
-$9.56M(+64.3%)
Mar 2004
-
$0.00(-100.0%)
-$5.82M(-30.5%)
Dec 2003
$0.00(0.0%)
-$321.00K(-89.7%)
-$8.37M(+4.0%)
Sep 2003
-
-$3.12M(+31.2%)
-$8.04M(-13.4%)
Jun 2003
-
-$2.38M(-6.7%)
-$9.29M(-33.4%)
Mar 2003
-
-$2.55M(<-9900.0%)
-$13.94M(-23.4%)
Dec 2002
$0.00(0.0%)
$0.00(-100.0%)
-$18.20M(0.0%)
Sep 2002
-
-$4.36M(-37.9%)
-$18.20M(+11.6%)
Jun 2002
-
-$7.03M(+3.2%)
-$16.30M(+32.0%)
Mar 2002
-
-$6.81M(<-9900.0%)
-$12.35M(+52.2%)
Dec 2001
$0.00(0.0%)
$0.00(-100.0%)
-$8.12M(0.0%)
Sep 2001
-
-$2.47M(-19.8%)
-$8.12M(+5.6%)
Jun 2001
-
-$3.08M(+19.4%)
-$7.69M(+8.6%)
Mar 2001
-
-$2.58M(<-9900.0%)
-$7.08M(+33.4%)
Dec 2000
$0.00(-100.0%)
$0.00(-100.0%)
-$5.30M(-27.0%)
Sep 2000
-
-$2.03M(-17.5%)
-$7.27M(+3.1%)
Jun 2000
-
-$2.47M(+206.5%)
-$7.05M(+13.5%)
Mar 2000
-
-$804.60K(-59.0%)
-$6.21M(-8.7%)
Dec 1999
-$6.73M(+8.7%)
-$1.96M(+8.2%)
-$6.81M(+40.5%)
Sep 1999
-
-$1.82M(+11.4%)
-$4.84M(+5.9%)
Jun 1999
-
-$1.63M(+16.5%)
-$4.57M(+7.8%)
Mar 1999
-
-$1.40M(<-9900.0%)
-$4.24M(+2.7%)
Dec 1998
-$6.19M(+127.2%)
$0.00(-100.0%)
-$4.13M(+5.1%)
Sep 1998
-
-$1.54M(+19.0%)
-$3.93M(+64.7%)
Jun 1998
-
-$1.30M(+0.7%)
-$2.39M(+202.6%)
Mar 1998
-
-$1.29M(-744.3%)
-$788.60K(-212.7%)
Dec 1997
-$2.72M(-553.8%)
$200.00K(-33.3%)
$700.00K(+40.0%)
Jun 1997
-
$300.00K(+50.0%)
$500.00K(+150.0%)
Mar 1997
-
$200.00K
$200.00K
Dec 1996
$600.00K
-
-

FAQ

  • What is Sarepta Therapeutics, Inc. annual gross profit?
  • What is the all time high annual gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. annual gross profit year-on-year change?
  • What is Sarepta Therapeutics, Inc. quarterly gross profit?
  • What is the all time high quarterly gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. quarterly gross profit year-on-year change?
  • What is Sarepta Therapeutics, Inc. TTM gross profit?
  • What is the all time high TTM gross profit for Sarepta Therapeutics, Inc.?
  • What is Sarepta Therapeutics, Inc. TTM gross profit year-on-year change?

What is Sarepta Therapeutics, Inc. annual gross profit?

The current annual gross profit of SRPT is $1.55B

What is the all time high annual gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high annual gross profit is $1.55B

What is Sarepta Therapeutics, Inc. annual gross profit year-on-year change?

Over the past year, SRPT annual gross profit has changed by +$496.56M (+47.35%)

What is Sarepta Therapeutics, Inc. quarterly gross profit?

The current quarterly gross profit of SRPT is $447.69M

What is the all time high quarterly gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high quarterly gross profit is $597.31M

What is Sarepta Therapeutics, Inc. quarterly gross profit year-on-year change?

Over the past year, SRPT quarterly gross profit has changed by +$138.03M (+44.57%)

What is Sarepta Therapeutics, Inc. TTM gross profit?

The current TTM gross profit of SRPT is $1.93B

What is the all time high TTM gross profit for Sarepta Therapeutics, Inc.?

Sarepta Therapeutics, Inc. all-time high TTM gross profit is $1.93B

What is Sarepta Therapeutics, Inc. TTM gross profit year-on-year change?

Over the past year, SRPT TTM gross profit has changed by +$637.41M (+49.45%)
On this page